Hsp60 derived peptides and peptide analogs for suppression and treatment of non autoimmune diabetes

摘要

The present invention provides methods of prevention and treatment of Type 2 diabetes (T2D) using peptides and analogs of heat shock protein 60 (hsp60) and for suppression prevention and treatment of complications associated with T2D. The invention is exemplified using DiaPep277™ a peptide analog of human hsp60. The invention further relates treatment regimens useful for suppression prevention or treatment of T2D.